Shire
SHP
Delayed London Stock Exchange - 07/18 05:35:23 pm
4404GBp
+0.86%
Prev.4366.5000
Open4369.0000
High4409.5000
Low4358.0000
Volume2 070 344
Financials
Sales 2018 15 469 M
EBIT 2018 5 776 M
R. net 2018 2 899 M
Debt 2018 14 980 M
Rend. 2018 0,64%
P/E ratio 2018 17,43
P/E ratio 2019 15,21
EV / Sales 2018 4,38x
EV / Sales 2019 4,02x
Capitalization 52 831 M
Company
Shire Plc is a biopharmaceutical company.It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs.The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin,...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-07-31 Earnings Release
Trading Rating :
Investor Rating :
Latest news
06:32pSHIRE : Form 8.5 (EPT/RI) - Shire plc amendment
PU
03:32pSHIRE : Form 8.3 -
PU
02:32pSHIRE : Form 8.5 (EPT/RI) - Replaces SHIRE PLC
PU
12:07pSHIRE : Form 8.3 - Shire plc
PU
12:07pSHIRE : Form 8.5 (EPT/RI) - SHIRE PLC
PU
11:32aSHIRE : Form 8.5 (EPT/NON-RI) - SHIRE PLC
PU
11:32aSHIRE : Form 8.5 - Shire Plc
PU
11:22aSHIRE : Form 8.3 - Takeda Pharmaceutical Company Limited
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance4 4865 0364 852
Spread/Res.-1,8%-13%-9,2%
Spread/Supp.4,9%24%22%
Support4 1993 5593 607